Comparison of Parameters of Chronic Kidney Disease Following Paediatric Preemptive Versus Non-preemptive Renal Transplantation
Overview
Authors
Affiliations
PRT is the preferred modality for renal replacement therapy in children. Despite this, there are no studies CKD parameters as per K/DOQI criteria between PRT and NPRT in children. This was a single-centre cross-sectional study of RTR with at least one yr of post-transplant follow-up. CKD parameters as per K/DOQI were compared between PRT and NPRT. Thirty percent (39/129) of our study population was PRT. Despite similar baseline characteristics at the time of transplantation and similar post-transplantation follow-up period, a significantly lower proportion of PRT (1, 2%) were in Stage 4 CKD in contrast to NPRT (14, 16%); p = 0.03. This was also reflected in better CKD parameters among PRT with significantly lower incidences of hypertension and acidosis (p = 0.02). CKD medications were also more commonly prescribed in NPRT (p = 0.002). We demonstrated improved CKD parameters and lower use of CKD medications among PRT when compared with NPRT. This finding should act as an added impetus for PRT programmes.
Rana Magar R, Knight S, Stojanovic J, Marks S, Lafranca J, Turner S Transpl Int. 2022; 35:10315.
PMID: 35368639 PMC: 8967954. DOI: 10.3389/ti.2022.10315.
Management of chronic renal allograft dysfunction and when to re-transplant.
Baker R, Marks S Pediatr Nephrol. 2018; 34(4):599-603.
PMID: 30039433 PMC: 6394652. DOI: 10.1007/s00467-018-4000-9.
Racial disparities in paediatric kidney transplantation.
Grace B, Kennedy S, Clayton P, McDonald S Pediatr Nephrol. 2013; 29(1):125-32.
PMID: 23928908 DOI: 10.1007/s00467-013-2572-y.
Factors influencing choice of renal replacement therapy in European paediatric nephrology units.
Watson A, Hayes W, Vondrak K, Ariceta G, Peter Schmitt C, Ekim M Pediatr Nephrol. 2013; 28(12):2361-8.
PMID: 23843162 DOI: 10.1007/s00467-013-2555-z.
Disparities, race/ethnicity and access to pediatric kidney transplantation.
Amaral S, Patzer R Curr Opin Nephrol Hypertens. 2013; 22(3):336-43.
PMID: 23508056 PMC: 3950976. DOI: 10.1097/MNH.0b013e32835fe55b.